Novartis investigative site

Saint Chares, Missouri 63301

0 studies enrolling now · 1 studies all time

What they study most

Chronic Obstructive Pulmonary Disease (COPD)

Studies at this site

• Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease — Completed